Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Aryeh Jason
Over the trailing 90 days, Aryeh Jason (Director at LIGAND PHARMACEUTICALS INC) traded $1.3M of stock (net selling $1.2M) across 3 companies, per 8 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 8 transactions · CIK 1376960
- Net activity
- −$1.2M ($37K bought · $1.2M sold)
By Company (Trailing 90 Days)
Transactions (8)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-23 | OBIO | Buy | 42.6K | $0 | Grant, award or other acquisition |
| 2026-06-11 | LGND | Sell | 4.5K | $1.1M | Open market or private sale |
| 2026-06-10 | LGND | Sell | 500 | $125K | Open market or private sale |
| 2026-06-05 | LGND | Buy | 2.9K | $0 | Grant, award or other acquisition |
| 2026-06-05 | LGND | Buy | 836 | $0 | Grant, award or other acquisition |
| 2026-06-04 | LFCR | Buy | 25.9K | $0 | Grant, award or other acquisition |
| 2026-05-18 | OBIO | Buy | 665 | $2K | Open market or private purchase |
| 2026-05-15 | OBIO | Buy | 9.0K | $35K | Open market or private purchase |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Aryeh's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.